Oncology Information System Market Report Scope & Overview:

The Oncology Information System Market Size was valued at USD 3.36 billion in 2023, and is expected to reach USD 6.13 billion by 2031, and grow at a CAGR of 7.8% over the forecast period 2024-2031.

Oncology Information System (OIS) is a piece of software used to manage and store patient profiles in health care facilities like clinics, hospitals, and research labs. Its objectives include enhancing efficiency, connecting various oncology skills, and ensuring the efficient use of resources to facilitate the smooth running of the oncology institute. This software provides a tool to track the profiles of a cancer patient, which is why it improves the efficiency and safety of patients. It is staffed in Medical Oncology, Surgical Oncology, and Radiation Oncology, among other things.

Oncology Information System Market Revenue Analysis

Get more information on Oncology Information System Market - Request Sample Report

Treatment delivery, Treatment plans, treatment summaries, patient treatment schedules, and results will all need to be managed through a system. The data presented above is managed using an oncology information system (OIS). The system connects radiation treatment departments with the rest of the healthcare system.



  • Costs of cancer care must be reduced.

  • EHRs and other oncology healthcare IT solutions are becoming more widely used, which is helping to improve patient care.

  • Cancer is becoming more common and is becoming more prevalent.

  • Government mandates that favour oncology information systems and support for them

  • Oncology information systems have the potential to aid patients and have advanced technologically.


  • Issues concerning interoperability

  • In the healthcare industry, there is a scarcity of skilled IT personnel



  • Concerns about data security


The emergence of COVID-19 has a profound impact on the field of oncology information systems. Government restrictions on closures and social reduction measures to combat the COVID-19 epidemic have led to the suspension of various activities, hampering business growth, cancellation of technical events, disruption of supply chain, and suspension of new development, all of which have had implications. in the production and sale of the whole, which limits the expansion of the industry. As a result of the suspension, the construction and delivery of essential health care items has had an impact on both. During the outbreak, many hospitals and cancer clinics were closed, reducing the need for OIS solutions. In addition, hospitals are increasingly focused on the management of COVID-19 patients, limiting their ability to market and deploy cancer information systems.

The demand for cancer information systems has declined as a result of the epidemic, as doctors were treating more COVID-19 patients than normal patients. On the other side, an increase in vaccination rates will help to keep the market stable. As a result, the market is expected to grow rapidly following COVID, as all of the previously delayed and postponed treatments will resume once the number of COVID cases decreases.

By Product & Service Type

Software and professional services have been separated from the market. Patient information systems and treatment planning systems are two types of software in the software category. Consulting/optimization services, implementation services, and post-sale & maintenance services are all included in the professional services category. When compared to traditional record maintenance methods, the software for patient information systems sector led the market in 2017. These systems provide benefits such as scheduled treatment and distant access due to digital availability.

By Application

Medical oncology, radiation oncology, and surgical oncology are the three segments of the market. Due to increased applications of OIS in efficiently managing, interpreting, analysing, and preserving patient information, as well as in predicting treatment results for patients, the medical oncology segment is expected to lead the market over the estimate period.

By End User

Hospitals and diagnostic centers, cancer care centers, government agencies, and research centers are all included. The active field of cancer information market was full of hospitals and diagnostic centers. The proliferation of government programs aimed at equipping (or improving) hospitals with new and improved programs, as well as the large amount of information generated during cancer screening and treatment and the significant number of annual patient visits around the world, are some of the driving factors. the growth of this phase.


By Product & Service Type

  • Software

    • Patient Information Systems

    • Treatment Planning Systems

  • Professional Services

    • Consulting/Optimization Services

    • Implementation Services

    • Post-sale & Maintenance Services

By Application

  • Medical Oncology

  • Radiation Oncology

  • Surgical Oncology

By End User

  • Hospitals & Oncology Clinics

  • Government Institutes

  • Research Centers

Oncology Information System Market Segmentation Analysis

Need any customization research on Oncology Information System Market - Enquiry Now


The highest revenue share came from the North American regional market. The presence of advanced healthcare infrastructure and increased awareness about patient information management in the region are two key elements driving this expansion. Furthermore, the expanding importance of EMR for making better treatment decisions and the growing implementation of OIS to follow and record treatment results of cancer patients are likely to promote regional market growth. The need for OIS in this region is likely to rise as the necessity for treatment schedule management, dosage control, and treatment planning grows.

Asian countries, on the other hand, have a strong demand for OIS and are gradually developing as a result of favourable government policies and increased understanding of the systems' benefits. This location could be a lucrative money source for players that want to take advantage of its possibilities. As a result, firms seeking a substantial portion of this market must adopt specific pricing policies as well as marketing tactics tailored to this region in order to gain a foothold in these profitable markets.


  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America


Some of the major key players of the Oncology Information System Market are as follows: Elekta AB, Accuray Inc., BrainLab, Cerner Corp., DOSIsoft S.A., Philips Healthcare, RaySearch Laboratories, Prowess, Inc., Varian Medical Systems, ViewRay Inc., Flatiron and Other Players.

BrainLab-Company Financial Analysis

Company Landscape Analysis

Oncology Information System Market Report Scope:
Report Attributes Details
Market Size in 2023  US$ 3.36 Billion
Market Size by 2031  US$ 6.13 Billion
CAGR  CAGR of 7.8% From 2024 to 2031
Base Year  2023
Forecast Period  2024-2031
Historical Data  2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product & Service Type (Software (Patient Information Systems, Treatment Planning Systems), Professional Services (Consulting/Optimization Services, Implementation Services, Post-sale & Maintenance Services)
• By Application (Medical Oncology, Radiation Oncology, Surgical Oncology)
• By End User (Hospitals & Oncology Clinics, Government Institutes, Research Centers)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Elekta AB, Accuray Inc., BrainLab, Cerner Corp., DOSIsoft S.A., Philips Healthcare, RaySearch Laboratories, Prowess, Inc., Varian Medical Systems, ViewRay Inc., Flatiron.
DRIVERS • Costs of cancer care must be reduced.
• EHRs and other oncology healthcare IT solutions are becoming more widely used, which is helping to improve patient care.
• Cancer is becoming more common and is becoming more prevalent.
RESTRAINTS • Issues concerning interoperability
• In the healthcare industry, there is a scarcity of skilled IT personnel.

Frequently Asked Questions

Ans: The Oncology Information System market is to grow at a CAGR of 7.6% over the forecast period 2023-2030.

Drivers, Restraints, Opportunities, and Challenges are the factors of marketing dynamics Population Health Management market.

Hospitals & Oncology Clinics, Government Institutes, and Research Centers are the sub segments of end use of Oncology Information System market.

Yes, this report covers qualitative and quantitative analysis.

Ans: The Oncology Information System Market size was valued at US$ 5.60 billion by 2030.

Table of Contents

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia war

4.3 Impact of ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7.  PEST Analysis


8. Oncology Information System Market Segmentation, By Product & Service Type

8.1 Software

8.1.1 Patient Information Systems

8.1.2 Treatment Planning Systems

8.2 Professional Services

8.2.1 Consulting/Optimization Services

8.2.2 Implementation Services

8.2.3 Post-sale & Maintenance Services

9. Oncology Information System Market Segmentation, By Application

9.1 Medical Oncology

9.2 Radiation Oncology

9.3 Surgical Oncology

10. Oncology Information System Market Segmentation, By End User

10.1 Hospitals & Oncology Clinics

10.2 Government Institutes

10.3 Research Centers

11. Regional Analysis

11.1 Introduction

11.2 North America

11.2.1 USA

11.2.2 Canada

11.2.3 Mexico

11.3 Europe

11.3.1 Germany

11.3.2 UK

11.3.3 France

11.3.4 Italy

11.3.5 Spain

11.3.6 The Netherlands

11.3.7 Rest of Europe

11.4 Asia-Pacific

11.4.1 Japan

11.4.2 South Korea

11.4.3 China

11.4.4 India

11.4.5 Australia

11.4.6 Rest of Asia-Pacific

11.5 The Middle East & Africa

11.5.1 Israel

11.5.2 UAE

11.5.3 South Africa

11.5.4 Rest

11.6 Latin America

11.6.1 Brazil

11.6.2 Argentina

11.6.3 Rest of Latin America

12.Company Profiles

12.1 Elekta AB

12.1.1 Financial

12.1.2 Products/ Services Offered

12.1.3 SWOT Analysis

12.1.4 The SNS view

12.2 Accuray Inc.

12.3 BrainLab, Cerner Corp.

12.4 DOSIsoft S.A.

12.5 Philips Healthcare

12.6 RaySearch Laboratories

12.7 Prowess, Inc.

12.8 Varian Medical Systems

12.9 ViewRay Inc.

12.10 Flatiron

13. Competitive Landscape

13.1 Competitive Benchmark

13.2 Market Share Analysis

13.3 Recent Developments

14. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone